Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Publication year range
2.
Z Gastroenterol ; 48(9): 1120-5, 2010 Sep.
Article in German | MEDLINE | ID: mdl-20839161

ABSTRACT

INTRODUCTION: In September 2007 an increase of severe Clostridium difficile-associated infections (CDI) was noticed in a hospital in the city of Trier, Germany. It was assumed that a new, possibly hypervirulent strain (PCR ribotype 027) was related to these events. An outbreak investigation was initiated by the local health authorities and the Robert Koch Institute to describe the epidemiology of the possible outbreak and to identify and control the possible sources. METHODS: In addition to retrospective case-finding of severe CDI and ribotype 027 infections by analysis of patient documents and certificates of death, an active surveillance system for severe CDI and ribotype 027 infections was established in the 6 hospitals of the affected region. In all suspected cases, a test for toxin A/B and a stool culture for C. difficile were conducted simultaneously. Bacterial isolates were further characterised by PCR ribotyping. Data on the course of disease, case fatality, and possible risk factors for CDI-related deaths were assessed using a standardised questionnaire. Environmental investigations were done. RESULTS: By 31 January 2008, 27 cases of severe CDI and 21 cases with C. difficile ribotype 027 infections were found in the area under investigation. Active surveillance found 76 of 399 (19 %) patients positive for C. difficile. In 20 patients, PCR ribotyp 027 could be proven. In total, 9 deaths occurred (19 %). An existing immunosupressive therapy (OR 35.8; 95 % CI 2.8 - 464.5) was related to case fatality in the multivariate analysis. Severe cases of CDI were also observed in non-ribotype 027 infections. In the screening of hospital personnel (n = 161), 6 % were found positive for toxin A/B. DISCUSSION: This investigation demonstrated the endemicity of C. difficile PCR ribotype 027 in Germany for the first time. As a consequence from this study, severe CDI became a reportable disease in Germany at the end of 2007. In addition to hygienic measures, the critical use of antibiotics is an important measure to prevent a further increase of CDI.


Subject(s)
Clostridium Infections/mortality , Communicable Diseases, Emerging/mortality , Disease Outbreaks/statistics & numerical data , Enterocolitis, Pseudomembranous/mortality , Clostridioides difficile/genetics , Clostridioides difficile/isolation & purification , Clostridium Infections/microbiology , Communicable Diseases, Emerging/microbiology , Enterocolitis, Pseudomembranous/microbiology , Female , Germany/epidemiology , Humans , Incidence , Male , Ribotyping , Survival Analysis , Survival Rate
3.
Eur J Med Res ; 14(1): 44-6, 2009 Jan 28.
Article in English | MEDLINE | ID: mdl-19258211

ABSTRACT

For intensively pretreated pediatric patients with human immunodeficiency virus type 1 (HIV-1) infection, the treatment options available are limited. We report the case of a highly treatment-experienced 12-year-old boy with multidrug-resistant HIV-1, who was successfully treated with highly active antiretroviral therapy (HAART) including ritonavir-boosted tipranavir oral solution, a novel non-peptic protease inhibitor, and enfuvirtide.


Subject(s)
Anti-HIV Agents/therapeutic use , Antiretroviral Therapy, Highly Active/methods , Drug Resistance, Multiple, Viral/drug effects , HIV Infections/drug therapy , HIV-1/drug effects , Child , Drug Therapy, Combination , Enfuvirtide , HIV Envelope Protein gp41/therapeutic use , HIV Infections/virology , Humans , Male , Peptide Fragments/therapeutic use , Pyridines/therapeutic use , Pyrones/therapeutic use , Remission Induction , Ritonavir/therapeutic use , Sulfonamides , Treatment Outcome
4.
Euro Surveill ; 13(45): pii: 19031, 2008 Nov 06.
Article in English | MEDLINE | ID: mdl-19000570

ABSTRACT

Following the fatal invasive meningococcal disease in a Swiss student who had been visiting Berlin, several public health institutions on local, regional and national level cooperated to ensure that the appropriate measures such as contact tracing and post exposure prophylaxis were taken to prevent further cases. The incidence highlighted the importance of early disease notification and showed that if an infectious disease requiring public health action occurs in an international context, it is vital that relevant information is communicated to all levels of the public health systems of the countries involved.


Subject(s)
Disease Outbreaks/statistics & numerical data , Meningitis, Meningococcal/epidemiology , Population Surveillance , Risk Assessment/methods , Travel , Adolescent , Fatal Outcome , Germany/epidemiology , Humans , Incidence , Risk Factors , Students , Switzerland/epidemiology
5.
Euro Surveill ; 13(31)2008 Jul 31.
Article in English | MEDLINE | ID: mdl-18761903

ABSTRACT

Outbreaks of Clostridium difficile infections (CDI) with increased severity, high relapse rate and significant mortality have been related to the emergence of a new, hypervirulent C. difficile strain in North America and Europe. This emerging strain is referred to as PCR ribotype 027 (Type 027). Since 2005, individual countries have developed surveillance studies about the spread of type 027.C. difficile Type 027 has been reported in 16 European countries. It has been responsible for outbreaks in Belgium, Germany, Finland, France, Ireland, Luxembourg, The Netherlands, Switzerland and the United Kingdom (England, Wales, Northern Ireland and Scotland). It has also been detected in Austria, Denmark, Sweden, Norway, Hungary, Poland and Spain. Three countries experienced imported patients with CDI due to Type 027 who acquired the infection abroad.The antimicrobial resistance pattern is changing, and outbreaks due to clindamycin-resistant ermB positive Type 027 strains have occurred in three European countries. Ongoing epidemiological surveillance of cases of CDI, with periodic characterisation of the strains involved, is required to detect clustering of cases in time and space and to monitor the emergence of new, highly virulent clones.


Subject(s)
Clostridioides difficile/genetics , Clostridioides difficile/pathogenicity , Disease Outbreaks , Enterocolitis, Pseudomembranous/epidemiology , Polymerase Chain Reaction , Ribotyping , Europe/epidemiology , European Union , Humans , Population Surveillance
7.
Clin Microbiol Infect ; 7(6): 326-30, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11442566

ABSTRACT

OBJECTIVE: This study aimed to establish interpretive criteria for agar diffusion tests with ceftibuten disks according to DIN standards. METHODS: Minimal inhibitory concentrations (MICs) and inhibition zones produced by ceftibuten in the disk diffusion test were determined for 275 recent bacterial isolates, including 11 species with 25 strains each. Regression analysis was performed for two disk loads (10 microg and 30 microg). RESULTS: Correlation of MICs and zone diameters was good, with correlation coefficients of r = - 0.97 for both tested disk loads. Evaluation of the calculated zone size criteria for all species showed no very major discrepancies or no major discrepancies. The 30-microg disks, however, produced unacceptably large inhibition zones for very susceptible strains, so that usage of 10-microg disks must be recommended when testing according to DIN standards. CONCLUSION: Based on the MIC breakpoints recommended by the DIN (> or =8 mg/L and < or = 1 mg/L), the following interpretive breakpoints for disk diffusion susceptibility tests with 10-microg ceftibuten disks were calculated using regression line analysis: < or =19 mm for resistance and > or = 27 mm for susceptiblity. Proposed inhibition zone diameters for the reference strain Escherichia coli ATCC 25922 are between 31 and 36 mm.


Subject(s)
Bacteria/drug effects , Cephalosporins/pharmacology , Microbial Sensitivity Tests/methods , Ceftibuten , Dose-Response Relationship, Drug , Microbial Sensitivity Tests/standards , Quality Control , Reference Values , Reproducibility of Results
8.
Antimicrob Agents Chemother ; 45(6): 1896-9, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11353648

ABSTRACT

The in vitro activity of gemifloxacin was compared to that of other quinolone and nonquinolone antimicrobials against 204 anaerobes by the agar dilution technique. The data indicate that gemifloxacin has a rather selective anaerobic activity. Most Peptostreptococcus, Porphyromonas, and Fusobacterium species are susceptible, while gemifloxacin's activity against other gram-negative anaerobes appears to be variable.


Subject(s)
Anti-Bacterial Agents/pharmacology , Bacteria, Anaerobic/drug effects , Fluoroquinolones , Naphthyridines/pharmacology , Gemifloxacin , Microbial Sensitivity Tests
SELECTION OF CITATIONS
SEARCH DETAIL
...